Skip to content
Find a Provider
Richard E. Wing, M.D.

Richard E. Wing, M.D.

Nephrology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-4517
Office (585) 275-4517
Fax (585) 442-9201
Administrative (585) 274-0202

Locations

General and Transplant Nephrology

601 Elmwood Avenue, 2nd & 3rd Floors
Rochester, NY 14642

Get Directions

About Me

Dr. Wing is Associate Professor of Medicine in the Division of Nephrology. His clinical practice is geared toward the entire breadth of general nephrology. His approach emphasizes patient autonomy and practical practical solutions to disease management issues. For every patient he seeks to balance t...
Dr. Wing is Associate Professor of Medicine in the Division of Nephrology. His clinical practice is geared toward the entire breadth of general nephrology. His approach emphasizes patient autonomy and practical practical solutions to disease management issues. For every patient he seeks to balance the issues of health, functional status, and quality of life.

Faculty Appointments

Associate Professor - Department of Medicine, Nephrology (SMD)

Credentials

Residency & Fellowship

Fellowship, Nephrology, University of Rochester Medical Center. 2004 - 2006

Residency, Internal Medicine, University of Rochester Medical Center. 2001 - 2003

Internship, Internal Medicine, University of Rochester Medical Center. 2000 - 2001

Education

MD | New Jersey Medical School. 2000

Awards

Buswell Fellowship. 2009 - 2010

Research

Over 70% of hemodialysis patients start dialysis using a hemodialysis catheter for vascular access despite clear evidence that using hemodialysis catheters, rather than AV fistulas or grafts, result in worsened patient health outcomes, worsened quality of life, and increased health costs. I use non-...
Over 70% of hemodialysis patients start dialysis using a hemodialysis catheter for vascular access despite clear evidence that using hemodialysis catheters, rather than AV fistulas or grafts, result in worsened patient health outcomes, worsened quality of life, and increased health costs. I use non-interventional research methods, such as retrospective cohort analysis, to illuminate approaches toward improving hemodialysis access.

Publications

Journal Articles

Outcomes Following In-Hospital Cardiopulmonary Resuscitation in People Receiving Maintenance Dialysis

Kidney Medicine. 2022; .

Publication Link

Long-Term Patency of Arteriovenous Fistulae

In-patient Permanent Access is associated with Reduced Catheter Time for Emergent Start Hemodialysis Patients

Catherine A. Moore; Michelle H. Malabanan; Scott E. Liebman; Susan L. Ziolkowski; and Richard E. Wing.

SM Journal of Nephrology and Therapeutics. 2016; 1(1): 1002-1006.

Assisted maturation for dialysis access: are the ends worth the means? A retrospective analysis of our institutional experience

Journal of Vascular and Interventional Radiology. 2015; 26(2): S49.

Assisted maturation of native fistula in two patients with a continuous flow left ventricular assist device.

Sasson T, Wing RE, Foster TH, Kashyap R, Butani D, Waldman DL

Journal of vascular and interventional radiology : JVIR.. 2014 May 25 (5):781-3. Epub 1900 01 01.

Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis

American Journal of Kidney Diseases. 2009; : 617-627.